Advertisement
Loading...

Cytokinetics, Incorporated

CYTK•NASDAQ
Healthcare
Biotechnology
$76.35
$-0.87(-1.13%)
U.S. Market is Open • 12:08

Cytokinetics, Incorporated (CYTK) Stock Overview

Explore Cytokinetics, Incorporated’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap9.8B
P/E Ratio-11.64
EPS (TTM)$-6.85
ROE1.40%
Fundamental Analysis

AI Price Forecasts

1 Month$55.70
3 Months$61.79
1 Year Target$67.86

CYTK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cytokinetics, Incorporated (CYTK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 68.67, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $67.86.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.64 and a market capitalization of 9.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.84%
5-Day Change
5.54%
1-Month Change
18.52%
3-Month Change
18.68%
6-Month Change
18.36%
Year-to-Date (YTD) Change
23.76%
1-Year Change
162.13%
3-Year Change
101.90%
5-Year Change
203.28%
All-Time (Max) Change
-18.59%

Contact Information

https://www.cytokinetics.com
650 624 3000
350 Oyster Point Boulevard, South San Francisco, CA, 94080

Company Facts

498 Employees
IPO DateApr 30, 2004
CountryUS
Actively Trading

Frequently Asked Questions